Altheus Therapeutics, Inc. Report issue

For profit Phase 2
Founded: Oklahoma City OK United States (2006)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2009
NCT01020708
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

mesalamine (rowasa) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1